FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025195280> ?p ?o ?g. }

• W3025195280 endingPage "45" @default.
• W3025195280 startingPage "39" @default.
• W3025195280 abstract "Estimate the tolerance of antituberculous drugs prescribed in the treatment of multi resistant tuberculosis on patients followed in the service of Pneumology of the University hospital of Yalgado Ouedraogo.It was a retrospective and prospective longitudinal investigation. The files of patients allowed to inform the questionnaire for the retrospective phase (2010-2011), the follow-up of patients during the prospective phase (2011-2013) allowed for data collection. All the patients under antituberculous treatment of 2nd line between January 1st, 2010 and the August 31st, 2013 were included.71 cases of multi resistant tuberculosis (MRT) were included. The sex-ratio was 3.4. The age bracket from 30 to 39 was the most represented (39.4 %). A notion of tubercular contage was found in 18 (25.3%) patients. All MRT patient had histories of treatment including aminoside lasting more than 2 months. Intolerance of the treatment was reported in 57 patients. Intolerance predominated in 30 to 39 years olds and in Tuberculosis/HIV co-infected patients. The neurological (47.9%) and psychiatric (47.9%) infringements were the most represented. Vestibulocochlear impact was seen in 42.3% of cases with 18.3% reporting of total deafness.The intolerance of the antituberculous treatment of the second line is real focus for clinicians. Shorter timeframes would avoid certain therapeutic modifications thought to be at the origin of failures.Apprécier la tolérance des antituberculeux prescrits dans le traitement de la tuberculose multi résistante chez les patients suivis dans le service de Pneumologie du Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU YO).Il s'est agi d'une enquête longitudinale rétrospective et prospective. Les dossiers des patients ont permis de renseigner le questionnaire pour la phase rétrospective (2010–2011), le suivi des patients durant la phase prospective (2011–2013) a permis la collecte des données. Etaient inclus tous les patients sous traitement antituberculeux de 2ème ligne entre le 1er Janvier 2010 et le 31 Aout 2013.Au total 71 cas de tuberculose multi résistante (TB-MDR) ont été recrutés. Le sex-ratio était 3,4. La tranche d'âge de 30 à 39 était la plus représentée (39,4%). Une notion de contage tuberculeux a été retrouvée chez 18 (25,3%) des patients. Tous les patients TB-MR avaient des antécédents de traitement incluant des aminosides de durée supérieure à 2 mois. L'intolérance au traitement a été rapportée chez 57 patients. Elle prédominait chez les 30 à 39 ans et chez les sujets co-infectés Tuberculose/VIH. Les atteintes neurologiques (47,9%) et psychiatriques (47,9%) étaient les plus représentées. L'atteinte vestibulo-cochléaire était de 42,3% avec 18,3% de surdité totale.l'intolérance du traitement antituberculeux de deuxième ligne est un véritable hantise pour le clinicien. Des régimes plus courts éviteraient certainement des modifications thérapeutiques à l'origine de survenue d'échecs." @default.
• W3025195280 created "2020-05-21" @default.
• W3025195280 creator A5004266413 @default.
• W3025195280 creator A5009266319 @default.
• W3025195280 creator A5015155103 @default.
• W3025195280 creator A5034742085 @default.
• W3025195280 creator A5042221153 @default.
• W3025195280 creator A5045599288 @default.
• W3025195280 creator A5050398089 @default.
• W3025195280 creator A5051928080 @default.
• W3025195280 creator A5052739305 @default.
• W3025195280 creator A5065359707 @default.
• W3025195280 creator A5068115159 @default.
• W3025195280 creator A5075493990 @default.
• W3025195280 creator A5075931545 @default.
• W3025195280 creator A5084834225 @default.
• W3025195280 creator A5084908202 @default.
• W3025195280 date "2015-01-01" @default.
• W3025195280 modified "2023-09-26" @default.
• W3025195280 title "[State of tolerance of multi resistant tuberculosis treatment (Burkina Faso)]." @default.
• W3025195280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29927133" @default.
• W3025195280 hasPublicationYear "2015" @default.
• W3025195280 type Work @default.
• W3025195280 sameAs 3025195280 @default.
• W3025195280 citedByCount "0" @default.
• W3025195280 crossrefType "journal-article" @default.
• W3025195280 hasAuthorship W3025195280A5004266413 @default.
• W3025195280 hasAuthorship W3025195280A5009266319 @default.
• W3025195280 hasAuthorship W3025195280A5015155103 @default.
• W3025195280 hasAuthorship W3025195280A5034742085 @default.
• W3025195280 hasAuthorship W3025195280A5042221153 @default.
• W3025195280 hasAuthorship W3025195280A5045599288 @default.
• W3025195280 hasAuthorship W3025195280A5050398089 @default.
• W3025195280 hasAuthorship W3025195280A5051928080 @default.
• W3025195280 hasAuthorship W3025195280A5052739305 @default.
• W3025195280 hasAuthorship W3025195280A5065359707 @default.
• W3025195280 hasAuthorship W3025195280A5068115159 @default.
• W3025195280 hasAuthorship W3025195280A5075493990 @default.
• W3025195280 hasAuthorship W3025195280A5075931545 @default.
• W3025195280 hasAuthorship W3025195280A5084834225 @default.
• W3025195280 hasAuthorship W3025195280A5084908202 @default.
• W3025195280 hasConcept C141071460 @default.
• W3025195280 hasConcept C142724271 @default.
• W3025195280 hasConcept C167135981 @default.
• W3025195280 hasConcept C187212893 @default.
• W3025195280 hasConcept C188816634 @default.
• W3025195280 hasConcept C2781069245 @default.
• W3025195280 hasConcept C71924100 @default.
• W3025195280 hasConceptScore W3025195280C141071460 @default.
• W3025195280 hasConceptScore W3025195280C142724271 @default.
• W3025195280 hasConceptScore W3025195280C167135981 @default.
• W3025195280 hasConceptScore W3025195280C187212893 @default.
• W3025195280 hasConceptScore W3025195280C188816634 @default.
• W3025195280 hasConceptScore W3025195280C2781069245 @default.
• W3025195280 hasConceptScore W3025195280C71924100 @default.
• W3025195280 hasIssue "4" @default.
• W3025195280 hasLocation W30251952801 @default.
• W3025195280 hasOpenAccess W3025195280 @default.
• W3025195280 hasPrimaryLocation W30251952801 @default.
• W3025195280 hasRelatedWork W114102227 @default.
• W3025195280 hasRelatedWork W131327980 @default.
• W3025195280 hasRelatedWork W1773183518 @default.
• W3025195280 hasRelatedWork W1941607223 @default.
• W3025195280 hasRelatedWork W2108227234 @default.
• W3025195280 hasRelatedWork W2236476785 @default.
• W3025195280 hasRelatedWork W2342282347 @default.
• W3025195280 hasRelatedWork W2401169593 @default.
• W3025195280 hasRelatedWork W2539398454 @default.
• W3025195280 hasRelatedWork W2574223084 @default.
• W3025195280 hasRelatedWork W2759675171 @default.
• W3025195280 hasRelatedWork W2920261985 @default.
• W3025195280 hasRelatedWork W2942730003 @default.
• W3025195280 hasRelatedWork W2946229458 @default.
• W3025195280 hasRelatedWork W2947644433 @default.
• W3025195280 hasRelatedWork W2954237726 @default.
• W3025195280 hasRelatedWork W3024674751 @default.
• W3025195280 hasRelatedWork W3150076666 @default.
• W3025195280 hasRelatedWork W815912092 @default.
• W3025195280 hasRelatedWork W2305827067 @default.
• W3025195280 hasVolume "30" @default.
• W3025195280 isParatext "false" @default.
• W3025195280 isRetracted "false" @default.
• W3025195280 magId "3025195280" @default.
• W3025195280 workType "article" @default.